Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
32.28
+0.33 (1.03%)
Nov 21, 2024, 10:59 AM EST - Market open
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.06 billion as of November 21, 2024. Its market cap has increased by 666.97% in one year.
Market Cap
3.06B
Enterprise Value
2.54B
1-Year Change
666.97%
Ranking
Category
Stock Price
$32.28
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.06B, an increase of 301.61%. That is a compound annual growth rate of 46.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.03B | 335.75% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | 761.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verona Pharma | 3.18B |
| MoonLake Immunotherapeutics | 3.14B |
| Agios Pharmaceuticals | 3.11B |
| Dyne Therapeutics | 3.05B |
| Veracyte | 3.04B |
| Bausch Health Companies | 3.01B |
| Xenon Pharmaceuticals | 3.00B |
| Amedisys | 2.95B |